Your browser doesn't support javascript.
Detection of concentration-dependent conformational changes in SARS-CoV-2 nucleoprotein by agarose native gel electrophoresis.
Sato, Ryo; Tomioka, Yui; Sakuma, Chiaki; Nakagawa, Masataka; Kurosawa, Yasunori; Shiba, Kohei; Arakawa, Tsutomu; Akuta, Teruo.
  • Sato R; Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna Takahagi-shi, Ibaraki, 318-0004, Japan. Electronic address: r.satou2@kyokutoseiyaku.co.jp.
  • Tomioka Y; Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna Takahagi-shi, Ibaraki, 318-0004, Japan. Electronic address: y.tomioka@kyokutoseiyaku.co.jp.
  • Sakuma C; Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna Takahagi-shi, Ibaraki, 318-0004, Japan. Electronic address: c.sakuma@kyokutoseiyaku.co.jp.
  • Nakagawa M; Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna Takahagi-shi, Ibaraki, 318-0004, Japan. Electronic address: m.nakagawa@kyokutoseiyaku.co.jp.
  • Kurosawa Y; Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna Takahagi-shi, Ibaraki, 318-0004, Japan; Abwiz Bio Inc., 9823 Pacific Heights Blvd., Suite J, San Diego, CA, 92121, USA. Electronic address: y.kurosawa@kyokutoseiyaku.co.jp.
  • Shiba K; Refeyn Japan, K.K., 1-1-14, Sakuraguchi-cho, Nada-ku, Kobe, Hyogo, 6570036, Japan. Electronic address: kohei.shiba@refeyn.com.
  • Arakawa T; Alliance Protein Laboratories, 13380 Pantera Rd, San Diego, CA, 92130, USA. Electronic address: tarakawa2@aol.com.
  • Akuta T; Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna Takahagi-shi, Ibaraki, 318-0004, Japan. Electronic address: t.akuta@kyokutoseiyaku.co.jp.
Anal Biochem ; 662: 114995, 2022 Nov 23.
Article in English | MEDLINE | ID: covidwho-2235275
ABSTRACT
The nucleoprotein (NP) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is abundantly expressed during infection, making it a diagnostic target protein. We analyzed the structure of the NP in solution using a recombinant protein produced in E. coli. A codon-optimized Profinity eXact™-tagged NP cDNA was cloned into pET-3d vector and transformed into E. coli T7 Express. The recombinant protein was first purified via chromatographic step using an affinity tag-based system that was followed by tag cleavage with sodium fluoride, resulting in proteolytic removal of the N-terminal tag sequence. The digested sample was then loaded directly onto a size exclusion chromatography run in the presence of L-Arg-HCl, resulting in removal of host nucleic acids and endotoxin. The molecular mass of the main NP fraction was determined by mass photometry as a dimeric form of NP, consistent with the blue native PAGE results. Interestingly, analysis of the purified NP by our newly developed agarose native gel electrophoresis revealed that it behaved like an acidic protein at low concentration despite its alkaline isoelectric point (theoretical pI = 10) and displayed a unique character of concentration-dependent charge and shape changes. This study should shed light into the behavior of NP in the viral life cycle.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Anal Biochem Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Anal Biochem Year: 2022 Document Type: Article